Diana M Cheng1, Natalia Pogrebnyak2, Peter Kuhn2, Alexander Poulev2, Carrie Waterman2, Patricio Rojas-Silva2, William D Johnson3, Ilya Raskin2. 1. Department of Plant Biology and Pathology, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA. Electronic address: Cheng@aesop.rutgers.edu. 2. Department of Plant Biology and Pathology, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA. 3. Department of Biostatistics, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Abstract
OBJECTIVE: The aims of the following experiments were to characterize antidiabetic in vitro and in vivo activity of the polyphenol-rich aqueous extract of Rutgers Scarlet Lettuce (RSL). METHODS: RSL extract (RSLE) and isolated compounds were evaluated for inhibitory effects on glucose production as well as tumor necrosis factor alpha-dependent inhibition of insulin activity in H4IIE rat hepatoma cells. Additionally, high-fat diet-induced obese mice were treated with RSLE (100 or 300 mg/kg), metformin (250 mg/kg), or vehicle (water) for 28 d by oral administration and insulin and oral glucose tolerance tests were conducted. Tissues were harvested at the end of the study and evaluated for biochemical and physiological improvements in metabolic syndrome conditions. RESULTS: A polyphenol-rich RSLE, containing chlorogenic acid, cyanidin malonyl-glucoside, and quercetin malonyl-glucoside, was produced by simple boiling water extraction at pH 2.0. In vitro, RSLE and chlorogenic acid demonstrated dose-dependent inhibition of glucose production. In vivo, RSLE treatment improved glucose metabolism measured by oral glucose tolerance tests, but not insulin tolerance tests. RSLE treated groups had a lower ratio of liver weight to body weight as well as decreased total liver lipids compared with the control group after 28 d of treatment. No significant differences in plasma glucose, insulin, cholesterol, and triglycerides were observed with RSLE-treated groups compared with vehicle control. CONCLUSION: RSLE demonstrated antidiabetic effects in vitro and in vivo and may improve metabolic syndrome conditions of fatty liver and glucose metabolism.
OBJECTIVE: The aims of the following experiments were to characterize antidiabetic in vitro and in vivo activity of the polyphenol-rich aqueous extract of Rutgers Scarlet Lettuce (RSL). METHODS:RSL extract (RSLE) and isolated compounds were evaluated for inhibitory effects on glucose production as well as tumor necrosis factor alpha-dependent inhibition of insulin activity in H4IIE rathepatoma cells. Additionally, high-fat diet-induced obesemice were treated with RSLE (100 or 300 mg/kg), metformin (250 mg/kg), or vehicle (water) for 28 d by oral administration and insulin and oral glucose tolerance tests were conducted. Tissues were harvested at the end of the study and evaluated for biochemical and physiological improvements in metabolic syndrome conditions. RESULTS: A polyphenol-rich RSLE, containing chlorogenic acid, cyanidin malonyl-glucoside, and quercetin malonyl-glucoside, was produced by simple boiling water extraction at pH 2.0. In vitro, RSLE and chlorogenic acid demonstrated dose-dependent inhibition of glucose production. In vivo, RSLE treatment improved glucose metabolism measured by oral glucose tolerance tests, but not insulin tolerance tests. RSLE treated groups had a lower ratio of liver weight to body weight as well as decreased total liver lipids compared with the control group after 28 d of treatment. No significant differences in plasma glucose, insulin, cholesterol, and triglycerides were observed with RSLE-treated groups compared with vehicle control. CONCLUSION:RSLE demonstrated antidiabetic effects in vitro and in vivo and may improve metabolic syndrome conditions of fatty liver and glucose metabolism.
Authors: Hsin-Chia Hung; Kaumudi J Joshipura; Rui Jiang; Frank B Hu; David Hunter; Stephanie A Smith-Warner; Graham A Colditz; Bernard Rosner; Donna Spiegelman; Walter C Willett Journal: J Natl Cancer Inst Date: 2004-11-03 Impact factor: 13.506
Authors: H Hemmerle; H J Burger; P Below; G Schubert; R Rippel; P W Schindler; E Paulus; A W Herling Journal: J Med Chem Date: 1997-01-17 Impact factor: 7.446
Authors: R S Surwit; M N Feinglos; J Rodin; A Sutherland; A E Petro; E C Opara; C M Kuhn; M Rebuffé-Scrive Journal: Metabolism Date: 1995-05 Impact factor: 8.694
Authors: Diana M Cheng; Diana E Roopchand; Alexander Poulev; Peter Kuhn; Isabel Armas; William D Johnson; Andrew Oren; David Ribnicky; Ehud Zelzion; Debashish Bhattacharya; Ilya Raskin Journal: Mol Nutr Food Res Date: 2016-08-16 Impact factor: 5.914
Authors: Csanad Gurdon; Alexander Kozik; Rong Tao; Alexander Poulev; Isabel Armas; Richard W Michelmore; Ilya Raskin Journal: Plant Physiol Date: 2021-06-11 Impact factor: 8.340
Authors: T S de Melo; P R Lima; K M M B Carvalho; T M Fontenele; F R N Solon; A R Tomé; T L G de Lemos; S G da Cruz Fonseca; F A Santos; V S Rao; M G R de Queiroz Journal: Braz J Med Biol Res Date: 2017-01-05 Impact factor: 2.590
Authors: Cristobal L Miranda; Lance A Johnson; Oriane de Montgolfier; Valerie D Elias; Lea S Ullrich; Joshua J Hay; Ines L Paraiso; Jaewoo Choi; Ralph L Reed; Johana S Revel; Chrissa Kioussi; Gerd Bobe; Urszula T Iwaniec; Russell T Turner; Benita S Katzenellenbogen; John A Katzenellenbogen; Paul R Blakemore; Adrian F Gombart; Claudia S Maier; Jacob Raber; Jan F Stevens Journal: Sci Rep Date: 2018-01-12 Impact factor: 4.379